Vanguard Portfolio Management
ARMP icon

Vanguard Portfolio Management’s Armata Pharmaceuticals ARMP Stock Holding History

Vanguard Portfolio Management’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$299K Buy
81,579
+225
+0.3% +$1.07K ﹤0.01% 3073
2026
Q2 		$527K Buy
+81,354
New +$746K ﹤0.01% 3054

Other funds holding ARMP

Madison Asset Management
Madison Asset Management Madison, Wisconsin $8.05B AUM 13.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
GWM
GSB Wealth Management Guilford, Connecticut $493M AUM 21.02% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $6.26B AUM 6.09% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SeaCrest Wealth Management
SeaCrest Wealth Management Purchase, New York $883M AUM 33.97% 1-Year Est. Return

Vanguard Portfolio Management's ARMP Position: Q3 2026 in Review

Vanguard Portfolio Management increased its Armata Pharmaceuticals (ARMP) stake by 0.28% in Q3 2026, buying an estimated $1.07K and bringing the position to 81,579 shares worth $299K. The position accounts for ﹤0.01% of the portfolio, ranked #3073.

Vanguard Portfolio Management first reported a position in ARMP in Q2 2026 and has held it in 2 quarters since. The position peaked at $527K in Q2 2026. 47 funds tracked by Wall St. Rank hold ARMP as of Q3 2026.

  • Vanguard Portfolio Management held 81,579 shares of Armata Pharmaceuticals worth $299K as of Q3 2026.
  • Vanguard Portfolio Management bought 225 Armata Pharmaceuticals shares in Q3 2026, an estimated $1.07K.
  • Armata Pharmaceuticals made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q3 2026, its #3073 holding.
  • Vanguard Portfolio Management first reported a position in Armata Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Armata Pharmaceuticals position peaked at $527K in Q2 2026.
  • 47 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2026.

Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.